Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | RASSF1 |
| Upstream (Parents) |
|---|
| (<<) ADAM17 → RASSF1 |
| (<<) ARID3B → RASSF1 |
| (<<) BCL2L1 → RASSF1 |
| (<<) BCL6 → RASSF1 |
| (<<) CASP3 → RASSF1 |
| (<<) CEP170 → RASSF1 |
| (<<) CSNK1E → RASSF1 |
| (<<) CYP1A2 → RASSF1 |
| (<<) DVL1 → RASSF1 |
| (<<) EIF2AK2 → RASSF1 |
| (<<) EWSR1 → RASSF1 |
| (<<) GPR153 → RASSF1 |
| (<<) MAP6D1 → RASSF1 |
| (<<) MAPK7 → RASSF1 |
| (<<) MPHOSPH6 → RASSF1 |
| (<<) PCK2 → RASSF1 |
| (<<) PIK3R2 → RASSF1 |
| (<<) PTPN11 → RASSF1 |
| (<<) TK2 → RASSF1 |
| (<<) TMEM87B → RASSF1 |
| (<<) VPS28 → RASSF1 |
| Downstream (Children) |
|---|
| RASSF1 → SPATA2L (>>) |
| RASSF1 → SUFU (>>) |
| RASSF1 → TCEB1 (>>) |
| RASSF1 → TUBA4A (>>) |
